Abstract
Myocardial ischemia–reperfusion injury (MIRI) is a pathological process characterized by cardiomyocyte death. Long noncoding RNAs (lncRNAs) have been shown to be dysregulated in the course of MIRI. Accordingly, the current study investigated the mechanism of lncRNA Rian in MIRI-induced cardiomyocyte pyroptosis. First, a murine model of MIRI was established by using the left anterior descending (LAD) coronary artery ligation method. Cardiac function and myocardial histopathological changes were evaluated by echocardiography and hematoxylin and eosin staining. Then, a cell model of MIRI was established by oxygen-glucose deprivation/reoxygenation (OGD/R), followed by analysis of NLRP3, cleaved caspase-1, and GSDMD-N levels by western blotting. The levels of IL-1β, IL-18, TNF-α, and IL-10 were measured using ELISA. LncRNA Rian, miR-17-5p, and CCND1 expression in myocardial tissues and OGD/R cells were examined using RT-qPCR. Finally, the binding relationships between Rian and miR-17-5p and miR-17-5p and CCND1 were validated with the help of dual-luciferase and RNA pull-down assays. Rian was poorly expressed in MIRI mice and OGD/R cells. LncRNA Rian overexpression reduced cardiomyocyte pyroptosis in vivo and in vitro, as indicated by decreased NLRP3, cleaved caspase-1, GSDMD-N, IL-1β, IL-18, and TNF-α levels and increased IL-10 levels. Furthermore, Rian bound to miR-17-5p and promoted CCND1 transcription. Notably, miR-17-5p overexpression or CCND1 silencing reversed the inhibitory effect of Rian overexpression on cardiomyocyte pyroptosis. Collectively, our findings indicate that Rian overexpression reduces cardiomyocyte pyroptosis and alleviates MIRI through the miR-17-5p/CCND1 axis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Frank A, Bonney M, Bonney S, Weitzel L, Koeppen M, Eckle T. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth. 2012;16:123–32.
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Investig. 2013;123:92–100.
Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med. 2011;17:1391–401.
Gong C, Zhou X, Lai S, Wang L, Liu J. Long noncoding RNA/Circular RNA-miRNA-mRNA axes in ischemia-reperfusion injury. Biomed Res Int. 2020;2020:8838524.
Korshunova AY, Blagonravov ML, Neborak EV, Syatkin SP, Sklifasovskaya AP, Semyatov SM, et al. BCL2regulated apoptotic process in myocardial ischemiareperfusion injury (Review). Int J Mol Med. 2021;47:23–36.
Wang Q, Wu J, Zeng Y, Chen K, Wang C, Yang S, et al. Pyroptosis: A pro-inflammatory type of cell death in cardiovascular disease. Clin Chim Acta. 2020;510:62–72.
Lou Y, Wang S, Qu J, Zheng J, Jiang W, Lin Z, et al. miR-424 promotes cardiac ischemia/reperfusion injury by direct targeting of CRISPLD2 and regulating cardiomyocyte pyroptosis. Int J Clin Exp Pathol. 2018;11:3222–35.
Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47–62.
Wang Y, Sun X. The functions of LncRNA in the heart. Diabetes Res Clin Pract. 2020;168:108249.
Ong SB, Katwadi K, Kwek XY, Ismail NI, Chinda K, Ong SG, et al. Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury. Expert Opin Ther Targets. 2018;22:247–61.
Tao X, Fang Y, Huo C. Long non-coding RNA Rian protects against experimental bronchopulmonary dysplasia by sponging miR-421. Exp Ther Med. 2021;22:781.
Bijkerk R, Au YW, Stam W, Duijs J, Koudijs A, Lievers E, et al. Long non-coding RNAs Rian and Miat mediate myofibroblast formation in kidney fibrosis. Front Pharmacol. 2019;10:215.
Yao P, Li YL, Chen Y, Shen W, Wu KY, Xu WH. Overexpression of long non-coding RNA Rian attenuates cell apoptosis from cerebral ischemia-reperfusion injury via Rian/miR-144-3p/GATA3 signaling. Gene. 2020;737:144411.
Liao J, Wang J, Liu Y, Li J, Duan L. Transcriptome sequencing of lncRNA, miRNA, mRNA and interaction network constructing in coronary heart disease. BMC Med Genom. 2019;12:124.
Abbas N, Perbellini F, Thum T. Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration. Basic Res Cardiol. 2020;115:52.
Zhong L, Jia J, Ye G. Rian/miR-210-3p/Nfkb1 feedback loop promotes hypoxia-induced cell apoptosis in myocardial infarction through deactivating the PI3K/Akt signaling pathway. J Cardiovasc Pharmacol. 2020;76:207–15.
Ma L, Wu K, Liu K, Gu S, Wang Y, Xu Z, et al. Changes of miRNA-17-5p, miRNA-21 and miRNA-106a level during rat kidney ischemia-reperfusion injury. Zhonghua Yi Xue Za Zhi. 2015;95:1488–92.
Chen J, Li X, Zhao F, Hu Y. HOTAIR/miR-17-5p axis is involved in the propofol-mediated cardioprotection against ischemia/reperfusion injury. Clin Inter Aging. 2021;16:621–32.
Ren X, Jing YX, Zhou ZW, Yang QM. MiR-17-5p inhibits cerebral hypoxia/reoxygenationinjury by targeting PTEN through regulation of PI3K/AKT/mTOR signaling pathway. Int J Neurosci. 2020; 1–9. https://doi.org/10.1080/00207454.2020.1806836.
Du W, Pan Z, Chen X, Wang L, Zhang Y, Li S, et al. By targeting Stat3 microRNA-17-5p promotes cardiomyocyte apoptosis in response to ischemia followed by reperfusion. Cell Physiol Biochem. 2014;34:955–65.
Ding S, Liu D, Wang L, Wang G, Zhu Y. Inhibiting MicroRNA-29a protects myocardial ischemia-reperfusion injury by targeting SIRT1 and suppressing oxidative stress and NLRP3-mediated pyroptosis pathway. J Pharmacol Exp Ther. 2020;372:128–35.
Hu F, Zhang S, Chen X, Fu X, Guo S, Jiang Z, et al. MiR-219a-2 relieves myocardial ischemia-reperfusion injury by reducing calcium overload and cell apoptosis through HIF1alpha/NMDAR pathway. Exp Cell Res. 2020;395:112172.
Sun L, Zhu W, Zhao P, Wang Q, Fan B, Zhu Y, et al. Long noncoding RNA UCA1 from hypoxia-conditioned hMSC-derived exosomes: a novel molecular target for cardioprotection through miR-873-5p/XIAP axis. Cell Death Dis. 2020;11:696.
Papoutsidakis N, Arkadopoulos N, Smyrniotis V, Tzanatos H, Kalimeris K, Nastos K, et al. Early myocardial injury is an integral component of experimental acute liver failure - a study in two porcine models. Arch Med Sci. 2011;7:217–23.
Gokalp O, Eygi B, Gokalp G, Kiray M, Besir Y, Iscan S, et al. Which distant organ is most affected by lower extremity ischemia-reperfusion? Ann Vasc Surg. 2020;65:271–81.
Wang S, Yao T, Deng F, Yu W, Song Y, Chen J, et al. LncRNA MALAT1 promotes oxygen-glucose deprivation and reoxygenation induced cardiomyocytes injury through sponging miR-20b to enhance beclin1-mediated autophagy. Cardiovasc Drugs Ther. 2019;33:675–86.
Walter S, Carlsson J, Schroder R, Neuhaus KL, Sorges E, Tebbe U. Enzymatic markers of reperfusion in acute myocardial infarct. With data from the ISAM study. Herz. 1999;24:430–9.
Wu F, Huang W, Tan Q, Guo Y, Cao Y, Shang J, et al. ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1. Cell Death Dis. 2021;12:614.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.
Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–7.
Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e050005.
Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS ONE. 2018;13:e0206239.
Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127–31.
Zhou H, Wang B, Yang YX, Jia QJ, Zhang A, Qi ZW, et al. Long noncoding RNAs in pathological cardiac remodeling: a review of the update literature. Biomed Res Int. 2019;2019:7159592.
Liu L, Li J, Wang R, Wang Y, Wang G. MicroRNA-298 exacerbates myocardial ischemic injury via targeting cyclin D1. Pharmazie. 2019;74:369–73.
Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–317.
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153–8.
Xu YJ, Zheng L, Hu YW, Wang Q. Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta. 2018;476:28–37.
Zhang J, Huang L, Shi X, Yang L, Hua F, Ma J, et al. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Aging. 2020;12:24270–87.
Wan X, Huang WJ, Chen W, Xie HG, Wei P, Chen X, et al. IL-10 deficiency increases renal ischemia-reperfusion injury. Nephron Exp Nephrol. 2014;128:37–45.
Liu H, Xu D, Zhong X, Xu D, Chen G, Ge J, et al. LncRNA-mRNA competing endogenous RNA network depicts transcriptional regulation in ischaemia reperfusion injury. J Cell Mol Med. 2019;23:2272–6.
Tchakarska G, Sola B. The double dealing of cyclin D1. Cell Cycle. 2020;19:163–78.
Chen ZD, Xu L, Tang KK, Gong FX, Liu JQ, Ni Y, et al. NF-kappaB-dependent transcriptional upregulation of cyclin D1 exerts cytoprotection against hypoxic injury upon EGFR activation. Exp Cell Res. 2016;347:52–9.
Guide for the Care and Use of Laboratory Animals. 8th edition. Washington (DC): National Academies Press (US); 2011. https://doi.org/10.17226/12910.
Acknowledgements
We thank all of the members of our team for their excellent work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
The current study was approved by the Ethics Committee of Sichuan University West China Hospital. All animal experimental protocols complied with the Guide for the Care and Use of Laboratory Animals [44]. Extensive efforts were made to minimize the number and suffering of the experimental animals.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kang, H., Yu, H., Zeng, L. et al. LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia–reperfusion injury by regulating by the miR-17-5p/CCND1 axis. Hypertens Res 45, 976–989 (2022). https://doi.org/10.1038/s41440-022-00884-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-022-00884-6
Keywords
This article is cited by
-
Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway
BMC Cardiovascular Disorders (2024)
-
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2
Clinical and Translational Oncology (2023)
-
Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome
Stem Cell Research & Therapy (2022)
-
Linking RNA dynamics to heart disease: the lncRNA/miRNA/mRNA axis in myocardial ischemia–reperfusion injury
Hypertension Research (2022)